Susquehanna International Group
AVNR

Susquehanna International Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Susquehanna International Group’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-411,600
Closed -$6.98M – 10587
2014
Q4 		$6.98M Sell
411,600
-677,000
-62% -$9.52M ﹤0.01% 2422
2014
Q3 		$13M Buy
1,088,600
+213,800
+24% +$1.46M 0.01% 1831
2014
Q2 		$4.93M Sell
874,800
-109,800
-11% -$506K ﹤0.01% 3105
2014
Q1 		$3.61M Buy
984,600
+578,800
+143% +$2.21M ﹤0.01% 3356
2013
Q4 		$1.36M Sell
405,800
-160,300
-28% -$662K ﹤0.01% 4938
2013
Q3 		$2.4M Sell
566,100
-2,800
-0.5% -$13.3K ﹤0.01% 3811
2013
Q2 		$2.62M Buy
+568,900
New +$1.96M ﹤0.01% 3482

Susquehanna International Group's AVNR Position: Q1 2015 in Review

Susquehanna International Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 611,025 shares — an estimated $10.4M sold.

Susquehanna International Group first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $10.4M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Susquehanna International Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Susquehanna International Group sold 611,025 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $10.4M.
  • Susquehanna International Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Susquehanna International Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $10.4M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Susquehanna International Group's 13F filing for Q1 2015, filed 15 May 2015.